Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
national blog main
national top stories
roche
6
×
boston blog main
boston top stories
clinical trials
san francisco top stories
san francisco blog main
boston
cancer
deals
fda
genentech
investing
novartis
alexion pharmaceuticals
alnylam pharmaceuticals
amgen
avapritinib
blueprint medicines
cancer drugs
eli lilly
europe top stories
hepatitis b
indiana blog main
indiana top stories
medullary thyroid cancer
national
new york top stories
non-small cell lung cancer
pralsetinib
selpercatinib
thyroid cancer
venture capital
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
What
drug
6
×
medicines
cancer
fda
roche
approval
blueprint
intended
new
patients
research
ret
team
therapy
address
advantages
approved
approves
atrophy
bar
bio
brings
candidate
carries
caught
causing
certain
currently
daily
designed
despite
dicerna
disease
evrysdi
expect
eye
family
friday
gamble
gene
Language
unset
6
×
Current search:
drug
×
unset
×
biotech
×
roche
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone